196 related articles for article (PubMed ID: 20493218)
1. Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat.
Matsuo K; Ishii Y; Quan YS; Kamiyama F; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
J Control Release; 2011 Jan; 149(1):15-20. PubMed ID: 20493218
[TBL] [Abstract][Full Text] [Related]
2. Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria.
Hirobe S; Matsuo K; Quan YS; Kamiyama F; Morito H; Asada H; Takaya Y; Mukai Y; Okada N; Nakagawa S
Vaccine; 2012 Feb; 30(10):1847-54. PubMed ID: 22230592
[TBL] [Abstract][Full Text] [Related]
3. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza.
Matsuo K; Hirobe S; Yokota Y; Ayabe Y; Seto M; Quan YS; Kamiyama F; Tougan T; Horii T; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jun; 160(3):495-501. PubMed ID: 22516091
[TBL] [Abstract][Full Text] [Related]
4. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
McCusker C; Somerville W; Grey V; Mazer B
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
[TBL] [Abstract][Full Text] [Related]
5. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
6. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
Popescu C; Durbaca S; Ivanov D
Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
[TBL] [Abstract][Full Text] [Related]
7. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
Tezel A; Paliwal S; Shen Z; Mitragotri S
Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant.
Naito S; Maeyama J; Mizukami T; Takahashi M; Hamaguchi I; Yamaguchi K
Vaccine; 2007 Dec; 25(52):8762-70. PubMed ID: 18023509
[TBL] [Abstract][Full Text] [Related]
9. Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant.
Rydell N; Sjöholm I
Vaccine; 2004 Mar; 22(9-10):1265-74. PubMed ID: 15003656
[TBL] [Abstract][Full Text] [Related]
10. Compositional optimization and safety assessment of a hydrogel patch as a transcutaneous immunization device.
Matsuo K; Ishii Y; Quan YS; Kamiyama F; Asada H; Mukai Y; Okada N; Nakagawa S
Biol Pharm Bull; 2011; 34(12):1835-40. PubMed ID: 22130239
[TBL] [Abstract][Full Text] [Related]
11. Combined diphtheria-tetanus immunization of adults.
Trinca JC
Med J Aust; 1975 Oct; 2(14):543-6. PubMed ID: 1196209
[TBL] [Abstract][Full Text] [Related]
12. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
[TBL] [Abstract][Full Text] [Related]
13. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
[TBL] [Abstract][Full Text] [Related]
15. Development of novel fusogenic vesosomes for transcutaneous immunization.
Mishra V; Mahor S; Rawat A; Dubey P; Gupta PN; Singh P; Vyas SP
Vaccine; 2006 Jul; 24(27-28):5559-70. PubMed ID: 16730102
[TBL] [Abstract][Full Text] [Related]
16. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
Someya S; Mizuhara H; Murata R; Kurokawa M
Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions.
Golaz A; Hardy IR; Glushkevich TG; Areytchiuk EK; Deforest A; Strebel P; Wharton M; Sutter RW
J Infect Dis; 2000 Feb; 181 Suppl 1():S203-7. PubMed ID: 10657215
[TBL] [Abstract][Full Text] [Related]
18. Diphtheria-tetanus overimmunization in children with no records: can it be prevented?
Frank JW; Schabas R; Arshinoff R; Brant R
CMAJ; 1989 Dec; 141(12):1241-6. PubMed ID: 2590890
[TBL] [Abstract][Full Text] [Related]
19. Combined vaccination with BCG and toxoid antigens.
Guld J; Ladefoged A; Ramhøj W
Bull World Health Organ; 1978; 56(6):957-64. PubMed ID: 310736
[TBL] [Abstract][Full Text] [Related]
20. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
